Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Hampson Industries, Bezant, Tangent Comms...

Thu, 26th Nov 2009 14:45

Aerospace and engineering group Hampson Industries reported a 32% slump in first half profit before tax to £11m on revenue down 12% to £97m."Although the immediate outlook for our core markets remains uncertain, present customer indications and the scale of new work in the pipeline all point to a gradual increase in the release of new orders in the months ahead," said chairman Chris Geoghegan."Tooling order books have increased in September and October and with leading indicators now generally more encouraging, we are cautiously optimistic of seeing further order strengthening over the second half."Gold and copper explorer Bezant lost £1.77m in the year ended 30 June 2009 due to its exploration activities in the Philippines and Tanzania.Executive chairman Gerry Nealon says Bezant's flagship Mankayan project in the Philippines has the potential to become a world class mine. News on future plans are expected early next yearPre-tax profit fell to £189,000 at Tangent Communications in the six months to 31 August, down from £500,000 in 2008, although the direct marketing firm says the outlook for the rest of the year is in line with management's expectations."The increased cost base from our recent acquisitions had a negative impact on the overall profitability, although we expect this investment in skills to deliver future growth in higher margin parts of the business," said the group.Stem cell developer ReNeuron narrowed losses from £3m to £2m in the year to September and said it has secured a two-year equity funding facility up to £5m from its joint broker, Matrix Corporate Capital.The AIM-listed firm said it remains confident of meeting the remaining requirements for its pioneering ReN001 therapy for stroke to allow initiation of a first-in-man clinical trial early next year.Alexon Group, the ladies clothing retailer, reports total sales for the 16 weeks to 21 November dropped 14% on a like for like basis.The firm blamed a 16.9% slump in sales for the first 8 weeks of the period on its decision to make fewer summer reductions, although they fell just 8.7% in the final 8 weeks. "Looking ahead, the board anticipates that the current price competitive environment will continue through the critical Christmas trading period and into the January sales. This is likely to adversely affect margins but the company's financial position remains secure," it said.
More News
10 Sep 2020 16:01

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

Read more
3 Sep 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
12 Aug 2020 13:35

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

Read more
31 Jul 2020 16:22

ReNeuron gets patent allowance in the US

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.

Read more
31 Jul 2020 11:28

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

Read more
29 Jun 2020 20:39

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

Read more
25 Jun 2020 14:55

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

Read more
25 Jun 2020 11:22

ReNeuron Group inks research evaluation deal with US firm

(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.

Read more
17 Jun 2020 15:58

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

Read more
3 Apr 2020 11:41

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

Read more
24 Feb 2020 12:24

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Read more
17 Feb 2020 10:29

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
6 Dec 2019 10:42

ReNeuron cuts losses after Fosun licence payment

(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.

Read more
6 Dec 2019 09:32

ReNeuron Reports "Strong Progress" Across Various Programmes

ReNeuron Reports "Strong Progress" Across Various Programmes

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.